ROBERT N WILSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT N WILSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT N WILSON. ROBERT N WILSON is Director in HESS CORP ($HES) and Director in SCHWAB CHARLES CORP ($SCHW) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA).
Latest Insider Trading Transactions of ROBERT N WILSON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HES, SNTA, SCHW
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 12.66 | 16,491 | 208,776 | 0 | |
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 19.21 | 14,345 | 275,567 | 0 | |
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 17.62 | 11,344 | 199,881 | 0 | |
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 41.75 | 6,600 | 275,534 | 193,282 | 199.9 K to 193.3 K (-3.30 %) |
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 41.75 | 5,000 | 208,738 | 199,882 | 204.9 K to 199.9 K (-2.44 %) |
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 41.75 | 4,787 | 199,845 | 204,882 | 209.7 K to 204.9 K (-2.28 %) |
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 17.62 | 11,344 | 199,881 | 209,669 | 198.3 K to 209.7 K (+5.72 %) |
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 19.21 | 14,345 | 275,567 | 198,325 | 184 K to 198.3 K (+7.80 %) |
| Dec 14 2018 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 12.66 | 16,491 | 208,776 | 183,980 | 167.5 K to 184 K (+9.85 %) |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 22.39 | 7,486 | 167,612 | 0 | |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 18.00 | 8,356 | 150,408 | 0 | |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 17.38 | 11,082 | 192,605 | 0 | |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 43.50 | 4,427 | 192,568 | 166,138 | 170.6 K to 166.1 K (-2.60 %) |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 43.50 | 3,853 | 167,600 | 170,565 | 174.4 K to 170.6 K (-2.21 %) |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 43.50 | 3,457 | 150,375 | 174,418 | 177.9 K to 174.4 K (-1.94 %) |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 22.39 | 7,486 | 167,612 | 177,875 | 170.4 K to 177.9 K (+4.39 %) |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 18.00 | 8,356 | 150,408 | 170,389 | 162 K to 170.4 K (+5.16 %) |
| Oct 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 17.38 | 11,082 | 192,605 | 162,033 | 151 K to 162 K (+7.34 %) |
| May 22 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | A | 38.33 | 7,165 | 274,634 | 7,165 | |
| May 22 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 1,831 | 0 | 150,951 | 149.1 K to 151 K (+1.23 %) |
| Apr 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 20.14 | 9,134 | 183,917 | 0 | |
| Apr 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 38.41 | 4,788 | 183,883 | 149,120 | 153.9 K to 149.1 K (-3.11 %) |
| Apr 20 2017 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 20.14 | 9,134 | 183,917 | 153,908 | 144.8 K to 153.9 K (+6.31 %) |
| May 23 2016 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | A | 28.96 | 7,866 | 227,799 | 7,866 | |
| May 23 2016 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 2,412 | 0 | 144,774 | 142.4 K to 144.8 K (+1.69 %) |
| Mar 03 2016 | HES | HESS CORP | WILSON ROBERT N | Director | Grant | A | 0.00 | 1,351 | 0 | 79,581 | 78.2 K to 79.6 K (+1.73 %) |
| Feb 09 2016 | HES | HESS CORP | WILSON ROBERT N | Director | Option Exercise | P | 0.00 | 6,000 | 0 | 6,000 | |
| Apr 19 2016 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 15.17 | 7,866 | 119,314 | 0 | |
| Apr 19 2016 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 28.58 | 4,174 | 119,293 | 142,362 | 146.5 K to 142.4 K (-2.85 %) |
| Apr 19 2016 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 15.17 | 7,866 | 119,314 | 146,536 | 138.7 K to 146.5 K (+5.67 %) |
| Sep 25 2015 | HES | HESS CORP | WILSON ROBERT N | Director | Buy | P | 49.76 | 3,000 | 149,290 | 78,230 | 75.2 K to 78.2 K (+3.99 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 6,818 | 0 | 760,936 | 754.1 K to 760.9 K (+0.90 %) |
| May 19 2015 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | A | 31.21 | 8,548 | 266,783 | 8,548 | |
| May 19 2015 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 2,227 | 0 | 138,670 | 136.4 K to 138.7 K (+1.63 %) |
| Apr 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Buy | P | 1.75 | 50,000 | 87,500 | 754,118 | 704.1 K to 754.1 K (+7.10 %) |
| Mar 23 2015 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Option Exercise | M | 11.04 | 7,866 | 86,841 | 0 | |
| Mar 23 2015 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Payment of Exercise | F | 29.40 | 2,953 | 86,818 | 136,443 | 139.4 K to 136.4 K (-2.12 %) |
| Mar 23 2015 | SCHW | SCHWAB CHARLES COR ... | WILSON ROBERT N | Director | Buy | M | 11.04 | 7,866 | 86,841 | 139,396 | 131.5 K to 139.4 K (+5.98 %) |
| Mar 05 2015 | HES | HESS CORP | WILSON ROBERT N | Director | Buy | P | 74.47 | 336 | 25,022 | 75,230 | 74.9 K to 75.2 K (+0.45 %) |
| Mar 05 2015 | HES | HESS CORP | WILSON ROBERT N | Director | Grant | A | 0.00 | 2,014 | 0 | 74,894 | 72.9 K to 74.9 K (+2.76 %) |
| Jan 06 2004 | HES | HESS CORP | WILSON ROBERT N | Director | Grant | A | 0.00 | 500 | 0 | 4,300 | 3.8 K to 4.3 K (+13.16 %) |
Page: 1